IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

By continuing, you agree to the Terms and Privacy Policy.

Use an existing password
Company dossier

Lincoln Pharmaceuticals

NSE:LINCOLN · ISIN INE405C01035

Close
Unavailable
Date unavailable
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
Lincoln Pharmaceuticals

Overview

Evidence state

Company record at a glance

Coverage in progress

Latest filing: Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Lincoln Pharmaceuticals Limited

Observed

Latest reported period: 31 Dec 2024 · revenue ₹146.6 Cr · PAT ₹20.8 Cr.

Exchange XBRL

Latest ownership: promoter group 49.78% and public 50.22% as of 30 Jun 2026.

Exchange XBRL

Latest rating action: Lincoln Pharmaceuticals Ltd.: Ratings reaffirmed

Agency source
Material events

What changed recently

Open timeline →
Observed

Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Lincoln Pharmaceuticals Limited

NSE · exchange filing

Source filing
Observed

Lincoln Pharmaceuticals Ltd - 531633 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE · exchange filing

Source filing
Observed

Trading Window - Lincoln Pharmaceuticals Limited

NSE · exchange filing

Source filing
Observed

Lincoln Pharmaceuticals Ltd - 531633 - Closure of Trading Window

BSE · exchange filing

Source filing
Reported financials

31 Dec 2024

Full financials →
Revenue from operations
₹146.6 Cr
Profit after tax
₹20.8 Cr
EPS
₹10.37

Observed NSE structured filing · Consolidated

Ownership

30 Jun 2026

Full shareholding →
Promoter group
49.78%
Public
50.22%
Employee trust
0.00%

Observed NSE shareholding XBRL